Virodene Pharmaceutical Holdings

Home page
	Articles
	-	VIRODENE -- the supposed Aids wonder drug developed by Pretoria University researcher Olga Visser and cardio-thoracic surgeons Callie Landauer and Professor Dirk du Plessis -- was put on ice by the Medicines Control Council this week. Click here to read more...
	-	From its very discovery, HIV/AIDS has generated bitter controversy, starting with the acrimonious tussle between the French & American researchers... Click here to read more...
	-	"Activation of the HIV type 1 Long Terminal Repeat and Viral Replication by Dimethylsulfoxide and related solvents." (Klebanoff et al) Click here to read more...
Products

About Us
	About Virodene Pharmaceutical Holdings (VPH) and other related companies
	-	MISSION STATEMENT
	-	INTRODUCTION
	-	HISTORY
	-	LEGAL HISTORY
	-	EXECUTIVE BROCHURE (pdf format, 0.8 Mb)
Contact Us

Articles
	www.cato.org/pubs/regulations
	-	We've discovered the biggest cause of cancer in laboratory animals
	-	NIV report re testing on anti HIV-1 activity of DMF(active ingredient of Virodene PO58^®
	-	"Activation of the HIV type 1 Long Terminal Repeat and Viral Replication by Dimethylsulfoxide and related solvents." (Klebanoff et al)
	-	Give Virodene and the Minister a break

Research & Development
	Clinical Research Organisation Participating in Research & Development of Virodene PO58^®
	-	Guy’s Drug Research unit (Quintiles) UK
	-	King’s College London
	-	Quintiles ClinData (South Africa)
	-	Quintiles Medicines Control Consultants (South Africa)
	-	Pretoria Technikon (South Africa)
	-	Farmovs (South Africa)
	-	Pharma Research Consultants (South Africa)
	-	Pathcare Pathology Group
	-	National Institute of Public Health - Czech Republic
	Know the Scientists
	Product
	Introduction
	Pilot Study - South Africa
	Phase I - London UK
	Phase II - Tanzania
	Reference